The Increasing Prevalence of Dental and Orthopedic Issues in the World Is Boosting the Growth of the Global Hydroxyapatite Market


Hydroxyapatite
Hydroxyapatite Market


Hydroxyapatite Market, By Type (Nano-sized, Micro-sized, Greater than Micrometers), By Application (Dental Care, Plastic Surgery, Orthopedic, Other Applications (Including Non- medical Applications)), By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030.

Market Overview:

Hydroxyapatite (HA) is a naturally occurring mineral form of calcium apatite. It is a crystalline substance with the chemical formula Ca10(PO4)6(OH)2. Hydroxyapatite is the main inorganic component of bones and teeth, making up approximately 70% of the weight of human bones and providing them with strength and rigidity.

Hydroxyapatite has a unique structure that closely resembles the mineral component of bone tissue. It is composed of calcium ions (Ca2+) and phosphate ions (PO43-) arranged in a hexagonal lattice. The presence of hydroxyl ions (OH-) in its chemical composition distinguishes it from other forms of calcium apatite.

The Hydroxyapatite Market size is estimated to be valued at US$ 2,250.19 Million in 2022 and is expected to exhibit a CAGR of 6.52% between 2023 and 2030.

Competitive Landscape:

Major players operating in the global hydroxyapatite market include Zimmer Biomet, Taihei Chemical Industrial Co. Ltd, SigmaGraft Biomaterials, SANGI CO. LTD, HOYA Technosurgical Corporation (HOYA Corporation), Granulab Sdn. Bhd. (KPower Berhad), FLUIDINOVA, CGbio, Bio-Rad Laboratories Inc., Berkeley Advanced Biomaterials (GNI Group Ltd), and APS Materials Inc.

Key Market Drivers:

The rising prevalence of orthopedic and dental disorders, coupled with the growing geriatric population, is expected to augment the growth of the global hydroxyapatite market. HA's excellent biocompatibility and ability to promote bone regeneration make it an ideal material for implants, coatings, and fillers.

Extensive research and development activities in the field of biomaterials and tissue engineering have led to advancements in hydroxyapatite-based products. Ongoing research focuses on enhancing the properties and performance of hydroxyapatite, further driving market growth.

The increasing number of orthopedic surgeries, such as joint replacements and spinal fusion procedures, is boosting the demand for hydroxyapatite-based implants. HA coatings on metal implants improve osseointegration, leading to better clinical outcomes and reduced implant failure rates.

With improving economic conditions and increasing healthcare spending, particularly in emerging economies, the demand for advanced medical treatments and devices, including hydroxyapatite-based products, is on the rise. This is estimated to enhance the growth of the global hydroxyapatite. For instance, in March 2022, Cgbio and Shanghai Sanyou Medical signed a five-year export contract for BONGROS for around US$ 27 million.

Covid-19 Impact Analysis:

The urgent need for medical supplies during the COVID-19 pandemic led to increased demand for hydroxyapatite-based products used in diagnostics, drug delivery systems, and vaccine development. The focus on improving healthcare infrastructure and preparedness also boosted the market. This boosted the growth of the global market. For instance, in April 2021, FLUIDINOVA initiated a new project called FLUIDINOVA - Innovation in Nanocrystalline Hydroxyapatite Offering Synthetics and Industrial/ Organizational Processes.

Key Takeaways:

· North America is expected to dominate the growth of the global market, owing to the presence of a well-established healthcare infrastructure, a high prevalence of orthopedic and dental disorders, and significant investments in research and development activities. The United States and Canada are the key contributors to the regional market growth. For instance, in March 2022, Zimmer Biomet Holdings Inc. completed its spinoff of ZimVie, which is the former spine and dental business of Zimmer Biomet.

· The Asia-Pacific region is estimated to witness high growth in the global market, owing to the rising healthcare expenditure, growing population, and increasing awareness about advanced medical treatments. China, Japan, and India are the key markets in this region. For instance, in March 2022, Cgbio signed an export contract with Kerunxi Medical for five years.


Comments

Post a Comment

Popular posts from this blog

Rising Adoption of AI in companies to boost AI Governance Market Growth

Image
AI Governance Market AI Governance Market is segmented by Component (Solution, Service), Deployment (Cloud, On-Premise), End-user Vertical (Healthcare, Government and Defense, Automotive, Retail, and BFSI), and By Regions (Asia Pacific, North America, Eastern Europe, Latin America, Western Europe, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023– 2030 The global AI Governance Market is estimated to be valued at US$ 131.9 million in 2022 and is expected to exhibit a CAGR of 46.60% over the forecast period, as highlighted in a new report published by Coherent Market Insights . Market Overview: Artificial Intelligence governance or AI governance is the procedure referring to a set of rules and policies to assure that the Artificial Intelligence and Machine Learning algorithms are advanced with the aim of fair Artificial Intelligence adoption for the people. Artificial Intelligence governance brings responsibility and traceability to ML designs – they ask
Read more

The Increasing Demand for Secure and Confidential Communication Is Boosting the Signal Jammer Market Growth

Image
Signal Jammer Market Signal Jammer Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Market Overview: , A signal jammer is an electronic device that is designed to block or disrupt wireless signals such as those used by mobile phones, GPS systems, and Wi-Fi networks. Signal jammers work by transmitting radio waves at the same frequency as the targeted device, effectively blocking the device's signal and preventing it from receiving or transmitting data. Signal jammers are often used in military and defense applications to prevent the use of communication devices by enemy forces. They are also used in other settings, such as prisons, to prevent unauthorized use of communication devices. However, the use of signal jammers is illegal in many countries, and their use can have unintended consequences, such as disrupting emergency communication systems. According to Coherent Market Insights the Signal Jammer Market Industry Insights, Trends, Outloo
Read more

Wearable Injector are Devices Which Adhere to the Body and Help in Administering Drug to the Patient

Image
Wearable Injector   A wearable injector is a medical device that enables the user to administer drugs through the skin. Injectors can be either prefilled or unfilled and are compatible with a variety of drugs. In addition, they are safe and convenient to use. There are several companies that have announced their intentions to develop such a device. Injectors can reduce the number of trips to the hospital for medication delivery. These devices are particularly useful for people who need to receive large volumes of medication and are not able to carry a syringe. The wearable device helps patients reduce the risk of acquiring infections while away from their homes. Several companies are developing wearable patch injectors that adhere to the patient's skin and administer liquid pharmaceuticals subcutaneously. These products can reduce the number of trips to the hospital and improve patient compliance and quality of life. Furthermore, the technology can also help increase adherence to t
Read more